These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28739343)

  • 1. Inhibition of Cell Apoptosis and Amelioration of Pulmonary Fibrosis by Thrombomodulin.
    Fujiwara K; Kobayashi T; Fujimoto H; Nakahara H; D'Alessandro-Gabazza CN; Hinneh JA; Takahashi Y; Yasuma T; Nishihama K; Toda M; Kajiki M; Takei Y; Taguchi O; Gabazza EC
    Am J Pathol; 2017 Oct; 187(10):2312-2322. PubMed ID: 28739343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of high-mobility group box 1 and thrombin in murine pulmonary fibrosis and the therapeutic potential of thrombomodulin.
    Kida T; Seno T; Nagahara H; Inoue T; Nakabayashi A; Kukida Y; Fujioka K; Fujii W; Wada M; Kohno M; Kawahito Y
    Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L473-L483. PubMed ID: 29212801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
    Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
    Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: A historically controlled study.
    Sakamoto S; Shimizu H; Isshiki T; Sugino K; Kurosaki A; Homma S
    Respir Investig; 2018 Mar; 56(2):136-143. PubMed ID: 29548651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIP/PAP protects against bleomycin-induced lung injury and inflammation and subsequent fibrosis in mice.
    Zheng X; Li Q; Tian H; Li H; Lv Y; Wang Y; He L; Huo Y; Hao Z
    J Cell Mol Med; 2020 Jun; 24(12):6804-6821. PubMed ID: 32352211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo.
    Ota C; Yamada M; Fujino N; Motohashi H; Tando Y; Takei Y; Suzuki T; Takahashi T; Kamata S; Makiguchi T; Yamaya M; Kubo H
    Exp Lung Res; 2015; 41(8):422-34. PubMed ID: 26151196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant Human Thrombomodulin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    Kataoka K; Taniguchi H; Kondoh Y; Nishiyama O; Kimura T; Matsuda T; Yokoyama T; Sakamoto K; Ando M
    Chest; 2015 Aug; 148(2):436-443. PubMed ID: 25811735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleomycin-induced pulmonary fibrosis is attenuated by an antibody against KL-6.
    Xu L; Yang D; Zhu S; Gu J; Ding F; Bian W; Rong Z; Shen C
    Exp Lung Res; 2013 Aug; 39(6):241-8. PubMed ID: 23672275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human soluble thrombomodulin treatment for acute exacerbation of idiopathic pulmonary fibrosis: a retrospective study.
    Isshiki T; Sakamoto S; Kinoshita A; Sugino K; Kurosaki A; Homma S
    Respiration; 2015; 89(3):201-7. PubMed ID: 25659984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: secondary analysis of the SETUP trial.
    Arai T; Kida H; Ogata Y; Marumo S; Matsuoka H; Gohma I; Yamamoto S; Mori M; Sugimoto C; Tachibana K; Akira M; Inoue Y
    BMJ Open Respir Res; 2020 May; 7(1):. PubMed ID: 32423894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant thrombomodulin for acute exacerbation in idiopathic interstitial pneumonias.
    Arai T; Kida H; Ogata Y; Marumo S; Matsuoka H; Gohma I; Yamamoto S; Mori M; Sugimoto C; Tachibana K; Akira M; Edahiro R; Hamasaki T; Inoue Y;
    Respirology; 2019 Jul; 24(7):658-666. PubMed ID: 30835911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
    Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
    J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of high mobility group box1 in pulmonary fibrosis.
    Hamada N; Maeyama T; Kawaguchi T; Yoshimi M; Fukumoto J; Yamada M; Yamada S; Kuwano K; Nakanishi Y
    Am J Respir Cell Mol Biol; 2008 Oct; 39(4):440-7. PubMed ID: 18441281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis: a proof of concept study.
    Tsushima K; Yamaguchi K; Kono Y; Yokoyama T; Kubo K; Matsumura T; Ichimura Y; Abe M; Terada J; Tatsumi K
    Pulm Pharmacol Ther; 2014 Dec; 29(2):233-40. PubMed ID: 24836398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotrophic tyrosine kinase receptor B/neurotrophin 4 signaling axis is perturbed in clinical and experimental pulmonary fibrosis.
    Avcuoglu S; Wygrecka M; Marsh LM; Günther A; Seeger W; Weissmann N; Fink L; Morty RE; Kwapiszewska G
    Am J Respir Cell Mol Biol; 2011 Oct; 45(4):768-80. PubMed ID: 21330466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant Thrombomodulin Modulates Murine Colitis Possibly via High-Mobility Group Box 1 Protein Inhibition.
    Ueda T; Higashiyama M; Narimatsu K; Yasutake Y; Kurihara C; Okada Y; Watanabe C; Yoshikawa K; Maruta K; Komoto S; Tomita K; Nagao S; Hokari R; Miura S
    Digestion; 2015; 92(2):108-19. PubMed ID: 26302768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of serum high-mobility group box protein 1 level with outcomes of acute exacerbation of idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia.
    Shimizu H; Sakamoto S; Isshiki T; Furuya K; Kurosaki A; Homma S
    PLoS One; 2018; 13(5):e0196558. PubMed ID: 29795561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caveolin-1-derived peptide limits development of pulmonary fibrosis.
    Marudamuthu AS; Bhandary YP; Fan L; Radhakrishnan V; MacKenzie B; Maier E; Shetty SK; Nagaraja MR; Gopu V; Tiwari N; Zhang Y; Watts AB; Williams RO; Criner GJ; Bolla S; Marchetti N; Idell S; Shetty S
    Sci Transl Med; 2019 Dec; 11(522):. PubMed ID: 31826982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ameliorative effect of mepenzolate bromide against pulmonary fibrosis.
    Kurotsu S; Tanaka K; Niino T; Asano T; Sugizaki T; Azuma A; Suzuki H; Mizushima T
    J Pharmacol Exp Ther; 2014 Jul; 350(1):79-88. PubMed ID: 24769542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and preclinical efficacy of novel transforming growth factor-β1 short interfering RNAs for pulmonary fibrosis.
    D'Alessandro-Gabazza CN; Kobayashi T; Boveda-Ruiz D; Takagi T; Toda M; Gil-Bernabe P; Miyake Y; Yasukawa A; Matsuda Y; Suzuki N; Saito H; Yano Y; Fukuda A; Hasegawa T; Toyobuku H; Rennard SI; Wagner PD; Morser J; Takei Y; Taguchi O; Gabazza EC
    Am J Respir Cell Mol Biol; 2012 Mar; 46(3):397-406. PubMed ID: 22033267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.